First Major Trial Win for Contemporary DOACs in Lower-Risk Afib
(MedPage Today) -- Emerging randomized data favored oral anticoagulation for lower-risk patients with atrial fibrillation (Afib), researchers found. Among patients with Afib and one thromboembolic risk factor in the SINGLE-AF trial, direct oral...
We haven't written up this one. MedPage Today has the full story — the link below goes straight to it.